Groupama Asset Management Reduces Boston Scientific Holdings

Institutional investor sells 77,295 shares of medical device company

Mar. 19, 2026 at 9:37am

Got story updates? Submit your updates here. ›

Groupama Asset Management, an institutional investor, reduced its holdings in Boston Scientific Corporation (NYSE:BSX) by 5.5% during the third quarter, according to a recent SEC filing. The firm now owns 1,332,481 shares of the medical equipment provider's stock, valued at $130,090,000.

Why it matters

Boston Scientific is a major medical device company, and changes in institutional ownership can signal shifts in investor sentiment around the stock. Groupama's reduction in its position may indicate broader concerns about the company's performance or outlook.

The details

According to the SEC filing, Groupama Asset Management sold 77,295 shares of Boston Scientific during the third quarter, reducing its total position to 1,332,481 shares. The firm previously owned 1,409,776 shares of the company. Boston Scientific is a global medical device manufacturer focused on less-invasive medical procedures across a range of therapeutic areas.

  • Groupama Asset Management filed its 13F report for the third quarter of the year on March 19, 2026.

The players

Groupama Asset Management

A French asset management firm that owns a significant stake in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Groupama's Boston Scientific holdings could signal broader concerns about the medical device company's performance or outlook, though the reasons behind the sell-off are not entirely clear. Investors will likely continue to monitor institutional ownership and sentiment around Boston Scientific as an indicator of the stock's prospects.